Characterisation of vancomycin-resistant enterococci from hospitalised patients at a tertiary centre over a seven-year period

Journal of Hospital Infection

Volumn 74, Issue 4, 2010, Pages 377-384

  Chang, C M ^a   Wang, L R ^a   Lee, H C ^a,b   Lee, N Y ^a   Wu, C J ^a   Ko, W C ^a,b  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Enterococcus faecalis; Enterococcus faecium; Vancomycin resistance

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; GENTAMICIN; LINEZOLID; STREPTOMYCIN; BACTERIAL DNA; BACTERIAL PROTEIN; ENTEROCOCCAL SURFACE PROTEIN, ESP; LIGASE; MEMBRANE PROTEIN; VANA LIGASE, BACTERIA; VANB PROTEIN, ENTEROCOCCUS; VIRULENCE FACTOR;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COLONIZATION; BACTERIAL TRANSMISSION; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CROSS RESISTANCE; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GENE CLUSTER; HOSPITAL PATIENT; INFECTION CONTROL; MOLECULAR TYPING; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; TERTIARY HEALTH CARE; VANCOMYCIN RESISTANT ENTEROCOCCUS; BACTERIUM IDENTIFICATION; CLUSTER ANALYSIS; DNA FINGERPRINTING; DRUG EFFECT; GENETICS; GRAM POSITIVE INFECTION; HUMAN; ISOLATION AND PURIFICATION; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; TAIWAN;

BACTERIAL PROTEINS; BACTERIAL TYPING TECHNIQUES; CARBON-OXYGEN LIGASES; CLUSTER ANALYSIS; DNA FINGERPRINTING; DNA, BACTERIAL; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOCCUS FAECALIS; ENTEROCOCCUS FAECIUM; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; MEMBRANE PROTEINS; MOLECULAR EPIDEMIOLOGY; TAIWAN; VANCOMYCIN RESISTANCE; VIRULENCE FACTORS;

EID: 77952555839     PISSN: 01956701     EISSN: 15322939     Source Type: Journal    
DOI: 10.1016/j.jhin.2009.10.025     Document Type: Article

References (37)

1. Uttley A.H., Collins C.H., Naidoo J., George R.C. Vancomycin-resistant enterococci. Lancet 1988, 1:57-58.
2. LeClercq R., Perlot E., Duval J., Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N Engl J Med 1988, 319:157-161.
3. National Nosocomial Infections Surveillance System. National Nosocomial Infections Surveillance (NNIS) System Report. Data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 2004;32:470-485.
4. Rice L.B. Antimicrobial resistance in gram-positive bacteria. Am J Med 2006, 119(6 Suppl. 1):S11-S19.
5. Ben R.-J., Lu J.-J., Young T.-G., et al. Clinical isolation of vancomycin-resistant Enterococcus faecalis in Taiwan. J Formos Med Assoc 1996, 95:946-949.
6. Yeh K.-M., Siu L.-K., Chang J.-C., Chang F.-Y. Vancomycin-resistant enterococcus (VRE) carriage and infection in intensive care units. Microb Drug Resist 2004, 10:177-183.
7. Hsueh P.-R., Teng L.-J., Pan H.-J., et al. Emergence of vancomycin-resistant enterococci at a university hospital in Taiwan: persistence of multiple species and multiple clones. Infect Control Hosp Epidemiol 1999, 20:828-833.
8. Jean S.-S., Fang C.-T., Wang H.-K., Hsueh P.-R., Chang S.-C., Luh K.-T. Invasive infections due to vancomycin-resistant enterococci in adult patients. J Microbiol Immunol Infect 2001, 34:281-286.
9. McDonald L.C., Lauderdale T.-L., Shiau Y.-R., et al. The status of antimicrobial resistance in Taiwan among Gram-positive pathogens: the Taiwan Surveillance of Antimicrobial Resistance (TSAR) programme, 2000. Int J Antimicrob Agents 2004, 23:362-370.
10. Hsueh P.-R., Chen W.-H., Teng L.-J., Luh K.-T. Nosocomial infections due to methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci at a university hospital in Taiwan from 1991 to 2003: resistance trends, antibiotic usage and in vitro activities of newer antimicrobial agents. Int J Antimicrob Agents 2005, 26:43-49.
11. Willems R.J.L., Homan W., Top J., et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 2001, 357:853-855.
12. Rice L.B., Carias L., Rudin S., et al. A potential virulence gene, hylEfm, predominates in Enterococcus faecium of clinical origin. J Infect Dis 2003, 187:508-512.
13. Khan M.A., van der Wal M., Farrell D.J., et al. Analysis of VanA vancomycin-resistant Enterococcus faecium isolates from Saudi Arabian hospitals reveals the presence of clonal cluster 17 and two new Tn1546 lineage types. J Antimicrob Chemother 2008, 62:279-283.
14. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing. 16th informational supplement. CLSI document 2006, M100-S16, CLSI, Wayne, PA.
15. National Committee for Clinical Laboratory Standards Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Approved Standard 2000, M7-A5, NCCLS, Wayne, PA. 5th edn.
16. Clark N.C., Cooksey R.C., Hill B.C., Swenson J.M., Tenover F.C. Characterization of glycopeptide-resistant enterococci from U.S. hospitals. Antimicrob Agents Chemother 1993, 37:2311-2317.
17. Klare I., Konstabel C., Mueller-Bertling S., et al. Spread of ampicillin/vancomycin-resistant Enterococcus faecium of the epidemic-virulent clonal complex-17 carrying the genes esp and hyl in German hospitals. Eur J Clin Microbiol Infect Dis 2005, 24:815-825.
18. Murray B.E., Singh K.V., Heath J.D., Sharma B.R., Weinstock G.M. Comparison of genomic DNAs of different enterococcal isolates using restriction endonucleases with infrequent recognition sites. J Clin Microbiol 1990, 28:2059-2063. (Published Erratum in J Clin Microbiol 1991; 29:418.).
19. Turabelidze D., Kotetishvili M., Kreger A., Morris J.G., Sulakvelidze A. Improved pulsed-field gel electrophoresis for typing vancomycin-resistant enterococci. J Clin Microbiol 2000, 38:4242-4245.
20. Tenover F.C., Arbeit R.D., Goering R.V., et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33:2233-2239.
21. Nelson R.R.S., McGregor K.F., Brown A.R., Amyes S.G.B., Young H.K. Isolation and characterization of glycopeptide-resistant enterococci from hospitalized patients over a 30-month period. J Clin Microbiol 2000, 38:2112-2116.
22. Zhanel G.G., Laing N.M., Nichol K.A., et al. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). J Antimicrob Chemother 2003, 52:382-388.
23. French G.L. Enterococci and vancomycin resistance. Clin Infect Dis 1998, 27(Suppl. 1):S75-S83.
24. Quintiliani R., Evers S., Courvalin P. The vanB gene confers various levels of self-transferable resistance to vancomycin in enterococci. J Infect Dis 1993, 167:1220-1223.
25. Williamson R., Al-Obeid S., Shlaes J.H., Goldstein F.W., Shlaes D.M. Inducible resistance to vancomycin in Enterococcus faecium D366. J Infect Dis 1989, 159:1095-1104.
26. Hayden M.K., Trenholme G.M., Schultz J.E., Sahm D.F. In vivo development of teicoplanin resistance in a VanB Enterococcus faecium isolate. J Infect Dis 1993, 167:1224-1227.
27. Kawalec M., Gniadkowski M., Kedzierska J., Skotnicki A., Fiett J., Hryniewicz W. Selection of a teicoplanin-resistant Enterococcus faecium mutant during an outbreak caused by vancomycin-resistant enterococci with the vanB phenotype. J Clin Microbiol 2001, 39:4274-4282.
28. Moellering R.C. Enterococcus species, Streptococcus bovis, and Leuconostoc species. Principles and practice of infectious diseases 2005, 2411-2421. Churchill Livingstone, Edinburgh. 6th edn. G.L. Mandell, J.E. Bennett, R. Dolin (Eds.).
29. Bell J.M., Paton J.C., Turnidge J. Emergence of vancomycin-resistant enterococci in Australia: phenotypic and genotypic characteristics of isolates. J Clin Microbiol 1998, 36:2187-2190.
30. Liassine N., Frei R., Jan I., Auckenthaler R. Characterization of glycopeptide-resistant enterococci from a Swiss hospital. J Clin Microbiol 1998, 36:1853-1858.
31. Lauderdale T.-L., McDonald L.C., Shiau Y.-R., et al. Vancomycin-resistant enterococci from humans and retail chickens in Taiwan with unique VanB phenotype-vanA genotype incongruence. Antimicrob Agents Chemother 2002, 46:525-527.
32. Hashimoto Y., Tanimoto K., Ozawa Y., Murata T., Ike Y. Amino acid substitutions in the VanS sensor of the VanA-type vancomycin-resistant Enterococcus strains result in high-level vancomycin resistance and low-level teicoplanin resistance. FEMS Microbiol Lett 2000, 185:247-254.
33. Arthur M., Depardieu F., Molinas C., Reynolds P., Courvalin P. The vanZ gene of Tn 1546 from Enterococcus faecium BM4147 confers resistance to teicoplanin. Gene 1995, 154:87-92.
34. van den Bogaard A.E., Jensen L.B., Stobberingh E.E. Vancomycin-resistant enterococci in turkeys and farmers. N Engl J Med 1997, 337:1558-1559.
35. Neely A.N., Maley M.P. Survival of enterococci and staphylococci on hospital fabrics and plastics. J Clin Microbiol 2000, 38:724-726.
36. Shankar N., Baghdayan A.S., Gilmore M.S. Modulation of virulence within a pathogenicity island in vancomycin-resistant Enterococcus faecalis. Nature 2002, 417:746-750.
37. Oancea C., Klare I., Witte W., Werner G. Conjugative transfer of the virulence gene, esp, among isolates of Enterococcus faecium and Enterococcus faecalis. J Antimicrob Chemother 2004, 54:232-235.